-
Although spring arrived late this year in parts of the United States, the summer allergy season will still be strong, according to a sinus expert at the University of Alabama at Birmingham.More >> Although spring arrived late this year in parts of the United States, the summer allergy season will still be strong, according to a sinus expert at the University of Alabama at Birmingham.More >> New research suggests the dominant side of your brain may make the call on which ear you choose to use while talking on your cellphone.More >> New research suggests the dominant side of your brain may make the call on which ear you choose to use while talking on your cellphone.More >> Film star Angelina Jolie will have her ovaries removed to help lower her odds for ovarian cancer, People magazine reported Wednesday.More >> Film star Angelina Jolie will have her ovaries removed to help lower her odds for ovarian cancer, People magazine reported Wednesday.More >> Weight gain in men and women is predicted by two different genetic variations -- so-called polymorphisms, according to a new study from the Netherlands.More >> Weight gain in men and women is predicted by two different genetic variations -- so-called polymorphisms, according to a new study from the Netherlands.More >> The notion of wealthy "sugar daddies" with young, pretty wives and well-heeled "cougar" women with handsome, young husbands may be more fiction than fact, new research suggests.More >> The notion of wealthy "sugar daddies" with young, pretty wives and well-heeled "cougar" women with handsome, young husbands may be more fiction than fact, new research suggests.More >> Close to half of U.S high school students text while driving, a habit that dramatically increases their risk of getting into a potentially fatal car crash, a new study shows.More >> Close to half of U.S high school students text while driving, a habit that dramatically increases their risk of getting into a potentially fatal car crash, a new study shows.More >> The widening American waistline may be feeding an epidemic of sleep apnea, potentially robbing millions of people of a good night's rest, a new study suggests.More >> The widening American waistline may be feeding an epidemic of sleep apnea, potentially robbing millions of people of a good night's rest, a new study suggests.More >> Next time you have a craving for fast food, don't kid yourself that choices today are much healthier, a new study says.More >> Next time you have a craving for fast food, don't kid yourself that choices today are much healthier, a new study says.More >> When a health insurer told obese people they could either pay 20 percent more for coverage or start exercising, most of them decided to get active, according to a new study.More >> When a health insurer told obese people they could either pay 20 percent more for coverage or start exercising, most of them decided to get active, according to a new study.More >> Significantly more U.S. children have a neurodevelopmental or mental health disability than did a decade ago, according to new research.More >> Significantly more U.S. children have a neurodevelopmental or mental health disability than did a decade ago, according to new research.More >>
Information contained on this page is provided by companies via press release distributed through PR Newswire, an independent third-party content provider. PR Newswire, WorldNow and this Station make no warranties or representations in connection therewith.
SOURCE Oncothyreon Inc.
SEATTLE, WA, Feb. 27, 2013 /PRNewswire/ - Oncothyreon Inc. (Nasdaq: ONTY)
announced today that Robert Kirkman, M.D., President and Chief
Executive Officer, will present at the Cowen and Company 33rd Annual Health Care Conference in Boston on Wednesday, March 6, 2013 at
8 a.m. Eastern.
A live and archived webcast of the presentation will be accessible by
visiting the Oncothyreon website www.oncothyreon.com under the "News & Events" section.
About Oncothyreon
Oncothyreon is a biotechnology company specializing in the development
of innovative therapeutic products for the treatment of cancer.
Oncothyreon's goal is to develop and commercialize novel synthetic
vaccines and targeted small molecules that have the potential to
improve the lives and outcomes of cancer patients. For more
information, visit www.oncothyreon.com.
©2012 PR Newswire. All Rights Reserved.
All content © Copyright 2000 - 2013 WorldNow and WTHR. For more information on this site, please read our Privacy Policy and Terms of Service.
